Form EFFECT Akari Therapeutics Plc
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | July 7, 2026 4:00 P.M. |
| Form: | S-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- OR Royalties Announces Preliminary Q2 2026 GEO Deliveries
- Ivanhoe Mines Reports 64,328 Tonnes of Copper Produced by Kamoa-Kakula in Q2 2026
- Pasithea Therapeutics Announces Participation in B. Riley Securities Mind, Muscle & Vision Summit
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
